Meryem Aktan

625 total citations
49 papers, 446 citations indexed

About

Meryem Aktan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Meryem Aktan has authored 49 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Meryem Aktan's work include Lung Cancer Research Studies (7 papers), Glioma Diagnosis and Treatment (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Meryem Aktan is often cited by papers focused on Lung Cancer Research Studies (7 papers), Glioma Diagnosis and Treatment (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Meryem Aktan collaborates with scholars based in Türkiye, United States and Japan. Meryem Aktan's co-authors include Mehmet Koç, Hüseyin Görkemli, Lütfi Saltuk Demir, Selçuk Duman, Mehmet Uyar, Mustafa Karaağaç, Önder Alpdoğan, Mustafa Koç, T Akoğlu and Sedat Yıldırım and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Meryem Aktan

39 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meryem Aktan Türkiye 13 121 110 89 85 66 49 446
Beth K. Neilsen United States 12 114 0.9× 173 1.6× 73 0.8× 32 0.4× 44 0.7× 34 583
Yueh-Yun Chi United States 16 322 2.7× 91 0.8× 47 0.5× 48 0.6× 18 0.3× 27 972
Inga Bekes Germany 12 47 0.4× 101 0.9× 98 1.1× 35 0.4× 6 0.1× 31 398
Nikolai Jaschke Germany 11 60 0.5× 94 0.9× 58 0.7× 70 0.8× 7 0.1× 25 375
Shin-ichi Yamashita Japan 15 165 1.4× 149 1.4× 100 1.1× 41 0.5× 12 0.2× 31 553
Stefano Aterini Italy 12 234 1.9× 45 0.4× 18 0.2× 78 0.9× 44 0.7× 30 712
Anish Bhatnagar United States 11 103 0.9× 164 1.5× 35 0.4× 132 1.6× 60 0.9× 30 585
Thomas Grünberger Austria 15 62 0.5× 188 1.7× 47 0.5× 66 0.8× 17 0.3× 29 689
Po‐Han Lin Taiwan 17 208 1.7× 263 2.4× 219 2.5× 79 0.9× 23 0.3× 38 784
Jae Seon Eo South Korea 19 236 2.0× 131 1.2× 132 1.5× 449 5.3× 8 0.1× 55 902

Countries citing papers authored by Meryem Aktan

Since Specialization
Citations

This map shows the geographic impact of Meryem Aktan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meryem Aktan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meryem Aktan more than expected).

Fields of papers citing papers by Meryem Aktan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meryem Aktan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meryem Aktan. The network helps show where Meryem Aktan may publish in the future.

Co-authorship network of co-authors of Meryem Aktan

This figure shows the co-authorship network connecting the top 25 collaborators of Meryem Aktan. A scholar is included among the top collaborators of Meryem Aktan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meryem Aktan. Meryem Aktan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Görken, İlknur Bilkay, Didem Çolpan Öksüz, Birsen Yücel, et al.. (2024). Who would be the winner? A prognostic nomogram for predicting the benefit of postoperative radiotherapy ± chemotherapy in patients with locally advanced gastric cancer: TROD-02-01 study. Asian Journal of Surgery. 47(7). 3056–3062.
2.
Aktan, Meryem, et al.. (2023). Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients. Journal of Neuro-Oncology. 165(3). 527–533. 5 indexed citations
3.
Aktan, Meryem, et al.. (2022). Assessment of Quality of Life Following Radiotherapy in Patients with Rectum Cancer. Journal of Gastrointestinal Cancer. 53(2). 502–510. 4 indexed citations
4.
Aktan, Meryem, et al.. (2022). Prognostic Factors in Patients with Triple Negative Breast Cancer Undergoing Adjuvant Radiotherapy: A 10-Year Single Center Experience. Archives of Breast Cancer. 377–385. 4 indexed citations
5.
6.
Aktan, Meryem, et al.. (2020). Factors affecting pathological response and survival following neoadjuvant chemoradiotherapy in rectal cancer patients. Indian Journal of Cancer. 58(4). 553–553. 3 indexed citations
7.
Käsmann, Lukas, Stefan Janssen, Tim J. Kruser, et al.. (2020). Prognostic factors and outcome of reirradiation for locally recurrent small cell lung cancer—a multicenter study. Translational Lung Cancer Research. 9(2). 232–238. 5 indexed citations
8.
Koç, Mehmet, et al.. (2019). Prognostic importance of PTEN, EGFR, HER-2, and IGF-1R in gastric cancer patients treated with postoperative chemoradiation. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(4). 1025–1032. 3 indexed citations
9.
Aktan, Meryem, et al.. (2019). Prognostic importance of 18F-fluorodeoxyglucose uptake by positron emission tomography for stage III non-small cell lung cancer treated with definitive chemoradiotherapy. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 39(1). 20–26. 7 indexed citations
10.
Aktan, Meryem, et al.. (2019). Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors. SHILAP Revista de lepidopterología. 15(4). 256–261. 37 indexed citations
11.
12.
Aktan, Meryem, et al.. (2018). Brain metastases from prostate cancer: A single-center experience. SHILAP Revista de lepidopterología. 45(4). 279–283. 18 indexed citations
13.
Aktan, Meryem, et al.. (2018). The prognostic effects of new eighth staging system for stage III non-small cell lung cancer. 11(1). 47–53. 1 indexed citations
14.
Aktan, Meryem, et al.. (2018). Intramedullary spinal cord metastasis and radiotherapy. Annals of Medical Research. 25(4). 445–445.
15.
Aktan, Meryem, et al.. (2017). Investigation of the Effects on Dose Distributions of Contrast Agents Used in Stomach Cancer Radiotherapy. 10(2). 45–48. 2 indexed citations
16.
Aktan, Meryem, et al.. (2017). Prognostic value of pre-treatment 18F-FDG-PET uptake in small-cell lung cancer. Annals of Nuclear Medicine. 31(6). 462–468. 16 indexed citations
17.
Aktan, Meryem, et al.. (2016). Cutaneous Metastases of the Synchronous Primary Endometrial and Bilateral Ovarian Cancer: An Infrequent Presentation and Literature Review. Case Reports in Oncological Medicine. 2016. 1–3. 8 indexed citations
18.
Aktan, Meryem, et al.. (2016). Thoracic Re-irradiation for Locally Recurrent Lung Cancer. PubMed. 17(11). 5041–5045. 5 indexed citations
19.
Aktan, Meryem, Anna Schuh, Peter Johansson, et al.. (2015). Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study. Leukemia & lymphoma. 56. 149–149. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth K. Neilsen Breakdown of academic impact, for papers by Yueh-Yun Chi Breakdown of academic impact, for papers by Inga Bekes Breakdown of academic impact, for papers by Nikolai Jaschke Breakdown of academic impact, for papers by Shin-ichi Yamashita Breakdown of academic impact, for papers by Stefano Aterini Breakdown of academic impact, for papers by Anish Bhatnagar Breakdown of academic impact, for papers by Thomas Grünberger Breakdown of academic impact, for papers by Po‐Han Lin Breakdown of academic impact, for papers by Jae Seon Eo
Rankless by CCL
2026